Harrow Health, Inc. Financial Ratios — HROW Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-371.72	-99.08	-57.76	-77.82	-130.46	-92.26	-46.85	39.87	0.31	-5.76	-23.12	-11.02	-10.4	-4.99	-1.3
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-22.09	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	-18.18	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	34.16	46.42	50.7	49.56	60.07	67.26	70.41	74.87	71.35	69.55	75.33	75.05
EBITDA Margin (%)	- -	-4,175.93	-76,812.2	-606.14	-146.27	-71.07	-38.84	-8.16	3.73	7.14	5.88	6.3	10.1	11.83	18.43
Operating Margin (%)	- -	-4,178.88	-76,868.79	-611.27	-152.55	-78.12	-45.43	-12.61	-1.48	1.53	2.57	2.17	0.62	4.55	11.21
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-65.52	4.72	0.35	-2.66	11.9	29.5
Pretax Margin (%)	- -	-5,383.54	-76,431.24	-609.52	-163.64	-96.27	-48.26	35.35	-0.23	-6.99	-24.66	-15.81	-18.21	-8.68	-0.5
Profit Margin (%)	- -	-5,383.54	-76,431.24	-609.52	-163.64	-95.71	-44.76	35.35	0.33	-6.87	-24.85	-15.9	-18.75	-8.76	-1.89
Net Income to Common Margin (%)	- -	-5,583.54	-76,431.24	-609.52	-163.64	-95.71	-44.76	35.35	0.33	-6.87	-25.5	-15.9	-18.75	-8.76	-1.89
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	9.49	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.87	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	- -	- -	- -	8	14	15	15	21	24	78	112	193	229	252
ST Debt	1	- -	- -	- -	- -	4	1	3	2	4	- -	1	1	- -	1
LT Debt	- -	- -	- -	- -	8	9	15	12	19	19	78	112	192	228	251
Total Debt/EBITDA	-1.52	- -	- -	- -	-0.59	-0.97	-1.47	-4.52	11	6.74	18.3	20.1	14.69	9.69	5.02
Net Debt/EBITDA	-1.37	2.4	2.03	0.76	-0.43	-0.22	-0.96	-2.34	4.84	3.49	6.92	1.42	8.5	7.3	3.39
Total Debt/EBIT	-1.52	- -	- -	- -	-0.56	-0.88	-1.26	-2.92	-27.8	31.46	41.84	58.48	238.24	25.22	8.26
Net Debt/EBIT	-1.37	2.4	2.03	0.76	-0.41	-0.2	-0.82	-1.51	-12.24	16.28	15.83	4.12	137.85	18.99	5.58
EBITDA to Interest Expense	-12.52	-169.35	- -	-2,647.89	- -	- -	- -	- -	- -	- -	- -	0.77	0.62	1.04	2.08
EBITDA-CapEx/Interest Expense	-12.52	-169.98	- -	-2,693.68	- -	- -	- -	- -	- -	- -	- -	-0.3	-6.54	-0.66	2.03
EBIT to Interest Expense	-12.52	-169.47	- -	-2,670.26	- -	- -	- -	- -	- -	- -	- -	0.26	0.04	0.4	1.26
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	21	23	24
Common Equity/Total Assets	-11,506.39	-225.08	-201.37	-408.67	-408.7	-281.98	-371.35	-150.02	-125.27	-134.62	-97	-69.55	-42.88	-38.91	-39.17
Long-Term Debt/Equity (%)	- -	- -	- -	0.23	- -	143.89	563.21	48.48	67.78	71	710.6	409.35	273.27	329.5	482.02
Long-Term Debt/Capital (%)	- -	- -	- -	-0.05	-16.88	-14.66	-20.04	-20.36	-34.85	-35.14	-436.9	4,624.89	326.17	296.06	263.93
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.19	59	33.97	61.58	24.26	31.45	33.14	79	70.85	61.64	58.7	62.85
Total Debt/Equity (%)	-84.15	- -	- -	0.53	-603.47	212.78	586.08	61.61	76.56	87.72	713.16	412	274.41	330.21	483.72
Total Debt/Capital (%)	-8.37	- -	- -	-0.1	-16.92	-21.67	-20.85	-25.87	-39.37	-43.42	-438.47	4,654.87	327.53	296.71	264.86
Total Debt/Total Assets (%)	888.73	- -	- -	0.42	59.15	50.23	64.08	30.83	35.53	40.95	79.28	71.31	61.9	58.83	63.08
Net Debt to Equity	-75.55	-100.39	-103.1	-94.43	-442.89	47.53	381.99	31.88	33.71	45.38	269.76	29.02	158.78	248.63	326.85
Net Debt/Capital (%)	-7.45	29.4	32.92	15.39	-11.78	-4.25	-12.89	-12.03	-15.92	-20.88	-49.19	-8.42	-740.69	576.69	766.68
EBITDA	-1	-4	-8	-10	-14	-14	-10	-3	2	3	4	6	13	24	50
EBITDA-CapEx	-1	-4	-8	-10	-15	-21	-11	-6	- -	2	-12	-2	-139	-15	49
Operating Income (Loss)	-1	-4	-8	-10	-15	-16	-12	-5	-1	1	2	2	1	9	31

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.08	14.14	23.95	5.26	0.5	0.89	0.7	2.36	2.44	3.01	5.21	5.47	1.68	0.52	0.76
Current Ratio	0.09	15.07	24.18	5.81	1.09	1.49	1.53	2.76	2.93	3.79	6.24	6.35	2.83	2.08	2.2
Quick Ratio	0.08	14.14	23.95	5.32	0.66	1.19	0.98	2.52	2.6	3.34	5.68	5.81	2.42	1.79	1.91
CFO/Avg Current Liab	-0.27	-1.48	-6.53	-6.38	-3.21	-1.47	-1.12	0.08	0.08	-0.1	0.5	0.12	0.11	-0.32	0.47
Common Equity/Total Assets	-11,506.39	-225.08	-201.37	-408.67	-408.7	-281.98	-371.35	-150.02	-125.27	-134.62	-97	-69.55	-42.88	-38.91	-39.17
Long-Term Debt/Equity (%)	- -	- -	- -	0.23	- -	143.89	563.21	48.48	67.78	71	710.6	409.35	273.27	329.5	482.02
Long-Term Debt/Capital (%)	- -	- -	- -	-0.05	-16.88	-14.66	-20.04	-20.36	-34.85	-35.14	-436.9	4,624.89	326.17	296.06	263.93
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.19	59	33.97	61.58	24.26	31.45	33.14	79	70.85	61.64	58.7	62.85
Total Debt/Equity (%)	-84.15	- -	- -	0.53	-603.47	212.78	586.08	61.61	76.56	87.72	713.16	412	274.41	330.21	483.72
Total Debt/Capital (%)	-8.37	- -	- -	-0.1	-16.92	-21.67	-20.85	-25.87	-39.37	-43.42	-438.47	4,654.87	327.53	296.71	264.86
Total Debt/Total Assets (%)	888.73	- -	- -	0.42	59.15	50.23	64.08	30.83	35.53	40.95	79.28	71.31	61.9	58.83	63.08
CFO/Total Liabilities	-15.65	-267.89	-682.26	-337.33	-71.82	-53.88	-41.32	2.78	3	-3.59	5.81	1.31	1.59	-6.95	12.63
CFO/CapEx	- -	-122.7	-221.91	-40.56	-9.44	-1.57	-8.2	0.31	0.52	-1.11	0.32	0.22	0.03	-0.57	39.8
Altman's Z-Score	-192.41	33.74	23.54	10.89	-11.44	-5.12	-6.16	1.79	3.26	3.09	1.66	2.35	1.26	2.92	4.42

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	40.99	21.1	10.6	12.03	24.03	26.08	20.93	20.32	16.53	6.13	2.62	2.4
Days Sales Outstanding	- -	- -	- -	8.91	17.3	34.42	30.33	15.19	13.99	17.44	17.96	22.08	59.59	139.55	152.32
Inventory Turnover	- -	- -	- -	5.86	5.83	6.04	6.6	8.09	6.52	3.98	4.45	4.72	4.55	4.57	5.61
Days Inventory Outstanding	- -	- -	- -	62.28	62.57	60.39	55.27	45.1	55.95	91.65	81.95	77.35	80.15	79.93	65.08
Accounts Payable Turnover	- -	- -	- -	2.67	2.98	2.95	3.75	3.64	2.88	2.6	4.06	4.77	3.16	1.63	1.91
Accounts Payable Turnover Days	- -	- -	- -	136.8	122.56	123.53	97.37	100.29	126.92	140.39	89.98	76.5	115.66	223.8	191.17
Cash Conversion Cycle	- -	- -	- -	-65.62	-42.69	-28.73	-11.77	-40	-56.97	-31.3	9.93	22.93	24.07	-4.32	26.22
Inventory to Cash Days	- -	- -	- -	-53.38	-45.27	-25.97	-24.94	-29.92	-41.96	-74.2	-63.99	-55.27	-20.56	59.61	87.24
Inventories	- -	- -	- -	- -	1	2	2	2	3	4	4	7	11	11	14
Raw Materials	- -	- -	- -	- -	1	1	1	1	2	3	2	4	5	5	7
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1
Finished Goods	- -	- -	- -	- -	1	1	1	1	1	1	2	3	5	4	6
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	2	44	29	68	66	32	34	125	197	177	231	408	365	1,196	1,799
- Cash & Cash Equivalents	- -	10	16	8	3	9	4	7	5	4	42	96	74	47	73
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	- -	- -	- -	8	14	15	15	21	24	78	112	193	229	252
Enterprise Value	3	34	14	60	72	37	45	112	188	168	258	418	475	1,377	1,977
Total Capital	-17	-24	-32	-42	-49	-63	-73	-59	-53	-54	-18	2	59	77	95
Total Debt/Capital (%)	-8.37	- -	- -	-0.1	-16.92	-21.67	-20.85	-25.87	-39.37	-43.42	-438.47	4,654.87	327.53	296.71	264.86
Total Debt / EV	0.45	- -	- -	- -	0.12	0.37	0.34	0.14	0.11	0.14	0.3	0.27	0.41	0.17	0.13
EV/Sales	- -	337.76	1,350.76	36.34	7.41	1.84	1.69	2.7	3.67	3.43	3.56	4.71	3.65	6.9	7.26
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	98.41	48.06	60.65	74.8	36.15	58.33	39.4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	224.29	138.66	217.66	586.19	151.77	64.8
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	162.88	197.65	- -	50.83	46.47	18.43	1,730.7	14.68
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	38.72	67.37	- -	12.3	24.92	2.67	34.9	14.56
Diluted Market Cap	2	44	29	68	66	32	34	135	206	177	231	408	365	1,196	1,799
Diluted Enterprise Value	3	34	14	60	72	37	45	144	222	196	267	423	484	1,377	1,977
EV per Share	8.03	7.52	1.56	6.61	7.52	2.88	2.26	5.11	7.41	6.5	9.65	15.12	14.58	38.63	53.87
TTM Sales	- -	- -	- -	2	10	20	27	41	51	49	72	89	130	200	272
TTM EBITDA	-1	-4	-8	-10	-14	-14	-10	-3	2	3	4	6	13	24	50
TTM Operating Income	-1	-4	-8	-10	-15	-16	-12	-5	-1	1	2	2	1	9	31
TTM Cash Flow to Firm	- -	-2	-4	-7	-11	-11	-9	1	1	-1	5	9	26	1	135
TTM Free Cash Flow to Firm	- -	-2	-4	-7	-10	-4	-8	3	3	- -	21	17	178	39	136

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-6.56	-23.24	-6.58	-9.95	-6.66	-7.82	-4.41	46.88	73.88	-1,671.19	11.02	43.01	2.34	72.61	40
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	224.29	138.66	217.66	586.19	151.77	64.8
Enterprise Value	3	34	14	60	72	37	45	112	188	168	258	418	475	1,377	1,977
Low Price	0.26	0.5	3.01	3.3	4.94	1.65	1.35	1.45	4.1	3.33	6	5.4	7.6	9.13	20.85
EV/Sales	- -	337.76	1,350.76	36.34	7.41	1.84	1.69	2.7	3.67	3.43	3.56	4.71	3.65	6.9	7.26
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	98.41	48.06	60.65	74.8	36.15	58.33	39.4
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	8.53	1,172.7	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-0.76	-4.1	-7.33	-6.57	-4.56	-2.55	-4.27	4.13	900.95	-43.22	-12.93	-16.95	-22.81	-53.32	-244.57
Price/Earnings High	-3.32	-12.8	-11.33	-8.68	-5.29	-4.63	-7.84	9.74	1,355.09	-60.69	-18.83	-29.69	-37.75	-120.79	-368.07
Price/Earnings Low	-0.1	-0.4	-3.41	-2.98	-2.98	-1.1	-2.26	2.17	618.01	-25.62	-8.7	-10.59	-10.15	-18.62	-148.93
Price/Book Value	-0.1	-1.82	-0.92	-1.64	-1.15	-0.41	-0.38	-1.68	-2.66	-2.29	-2.43	-3.72	-2.73	-7.9	-11.49
Price/Book Value Average	-0.04	-0.95	-1.76	-1.59	-1.26	-0.63	-0.58	-0.81	-2.04	-1.88	-2.51	-2.18	-4.16	-6.16	-8.03
Price/Book Value High	-0.19	-2.96	-2.73	-2.1	-1.46	-1.15	-1.06	-1.92	-3.08	-2.63	-3.65	-3.82	-6.88	-13.95	-12.09
Price/Book Value Low	-0.01	-0.09	-0.82	-0.72	-0.82	-0.27	-0.3	-0.43	-1.4	-1.11	-1.68	-1.36	-1.85	-2.15	-4.89
Price/Tangible Book Value	-1.12	4.38	1.92	9.5	-9.5	25.84	-13.77	6.41	7.96	7.39	-35.45	380.64	-3.97	-10.16	-14.44
Price/Tangible Book Value Average	-0.47	2.29	3.71	9.22	-10.39	39.51	-20.68	3.1	6.12	6.05	-36.62	222.87	-6.06	-7.92	-10.09
Price/Tangible Book Value High	-2.06	7.15	5.73	12.19	-12.05	71.73	-38	7.32	9.2	8.5	-53.3	390.44	-10.02	-17.94	-15.18
Price/Tangible Book Value Low	-0.06	0.22	1.72	4.18	-6.77	17.05	-10.94	1.63	4.2	3.59	-24.62	139.26	-2.7	-2.76	-6.14
Price/Sales	- -	438.12	2,908.69	41.26	6.83	1.6	1.27	3.01	3.85	3.62	3.19	4.6	2.81	5.99	6.61
Price/Sales Average	- -	229.16	5,600.52	40.03	7.47	2.44	1.91	1.46	2.96	2.97	3.3	2.69	4.28	4.67	4.62
Price/Sales High	- -	714.47	8,656.82	52.93	8.66	4.43	3.51	3.44	4.45	4.17	4.8	4.72	7.08	10.58	6.95
Price/Sales Low	- -	22.47	2,605.7	18.16	4.87	1.05	1.01	0.77	2.03	1.76	2.22	1.68	1.9	1.63	2.81
Price/Cash Flow	-6.56	-23.05	-6.55	-9.71	-5.96	-2.84	-3.87	181.53	207.38	-161.04	45.53	239.1	95.13	-53.87	41.01
Price/Cash Flow Average	-2.76	-12.06	-12.62	-9.42	-6.51	-4.34	-5.81	87.92	159.33	-131.91	47.03	140	145.03	-41.98	28.65
Price/Cash Flow High	-12.02	-37.59	-19.5	-12.45	-7.55	-7.89	-10.67	207.37	239.64	-185.22	68.45	245.26	239.95	-95.11	43.12
Price/Cash Flow Low	-0.35	-1.18	-5.87	-4.27	-4.25	-1.87	-3.07	46.26	109.29	-78.17	31.62	87.48	64.55	-14.66	17.45
Price/Free Cash Flow Average	-2.76	-12.15	-12.67	-9.65	-7.28	-11.95	-6.62	22.71	56.76	-1,368.93	11.38	25.18	3.56	56.58	27.95
Price/Free Cash Flow High	-12.02	-37.9	-19.59	-12.76	-8.45	-21.7	-12.15	53.56	85.37	-1,922.11	16.56	44.12	5.89	128.19	42.07
Price/Free Cash Flow Low	-0.35	-1.19	-5.9	-4.38	-4.75	-5.16	-3.5	11.95	38.93	-811.23	7.65	15.74	1.59	19.76	17.02
EV/Sales Average	- -	128.81	4,042.59	35.11	8.05	2.68	2.33	1.67	3.27	3.36	3.79	2.87	5.19	5.58	5.27
EV/Sales High	- -	614.12	7,098.89	48.01	9.25	4.68	3.93	3.65	4.76	4.56	5.29	4.9	7.99	11.49	7.6
EV/Sales Low	- -	- -	1,047.77	13.24	5.45	1.3	1.43	0.98	2.34	2.15	2.71	1.86	2.82	2.54	3.47
EV/EBITDA Average	-2.23	-3.08	-5.26	-5.79	-5.5	-3.78	-6	-20.45	87.69	47.03	64.43	45.54	51.38	47.15	28.6
EV/EBITDA High	-5.1	-14.71	-9.24	-7.92	-6.32	-6.58	-10.12	-44.78	127.68	63.83	90	77.68	79.1	97.1	41.25
EV/EBITDA Low	-1.48	1.87	-1.36	-2.18	-3.73	-1.82	-3.69	-11.97	62.77	30.1	46.05	29.5	27.88	21.46	18.81
EV/EBIT Average	-2.22	-3.08	-5.26	-5.74	-5.28	-3.44	-5.13	-13.23	-221.6	219.5	147.3	132.51	833.16	122.67	47.04
EV/EBIT High	-5.09	-14.7	-9.24	-7.85	-6.06	-5.99	-8.65	-28.96	-322.65	297.89	205.75	226.04	1,282.61	252.65	67.84
EV/EBIT Low	-1.48	1.86	-1.36	-2.17	-3.57	-1.66	-3.15	-7.74	-158.64	140.47	105.27	85.85	452.11	55.84	30.94
Last Price	4.8	9.75	3.36	7.5	6.93	2.5	1.7	5.69	7.78	6.86	8.64	14.76	11.2	33.55	49
High Price	8.8	15.9	10	9.62	8.79	6.94	4.69	6.5	8.99	7.89	12.99	15.14	28.25	59.23	51.53
Enterprise Value Average	2	13	40	58	78	54	62	69	167	164	274	254	676	1,113	1,436
Enterprise Value High	5	61	71	80	90	93	105	151	244	223	383	434	1,040	2,293	2,070
Enterprise Value Low	1	-8	10	22	53	26	38	40	120	105	196	165	367	507	944

Shares Outstanding	- -	7	9	9	10	19	21	24	26	26	27	30	35	36	37
Diluted Weighted Avg Shares	- -	4	9	9	10	13	20	24	26	26	27	28	33	36	37
Basic Weighted Avg Shares	- -	4	9	9	10	13	20	22	25	26	27	28	33	36	37
Revenue per Share	- -	0.02	- -	0.18	1.01	1.56	1.34	1.89	2.02	1.89	2.71	3.21	3.99	5.6	7.42
EBITDA per Share	-2.36	-0.93	-0.89	-1.1	-1.48	-1.11	-0.52	-0.15	0.08	0.14	0.16	0.2	0.4	0.66	1.37
Operating Income per Share	-2.36	-0.93	-0.89	-1.11	-1.55	-1.22	-0.61	-0.24	-0.03	0.03	0.07	0.07	0.02	0.25	0.83
Basic EPS, GAAP	-2.65	-1.24	-0.88	-1.11	-1.66	-1.5	-0.6	0.67	0.01	-0.13	-0.69	-0.51	-0.75	-0.49	-0.14
Basic EPS from Cont Ops	-2.4	-1.2	-0.88	-1.11	-1.66	-1.5	-0.6	0.67	- -	-0.13	-0.67	-0.51	-0.75	-0.49	-0.14
Diluted EPS, GAAP	-2.65	-1.24	-0.88	-1.11	-1.66	-1.5	-0.6	0.61	0.01	-0.13	-0.69	-0.51	-0.75	-0.49	-0.14
Diluted EPS from Cont Ops	-2.4	-1.2	-0.88	-1.11	-1.66	-1.5	-0.6	0.61	- -	-0.13	-0.67	-0.51	-0.75	-0.49	-0.14
Dividend per Share	- -	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.73	-0.42	-0.51	-0.77	-1.16	-0.88	-0.44	0.03	0.04	-0.04	0.19	0.06	0.12	-0.62	1.19
Free Cash Flow per Basic Share	-0.73	-0.43	-0.52	-0.79	-1.29	-1.44	-0.49	-0.07	-0.04	-0.08	-0.4	-0.22	-4.56	-1.71	1.16
Cash & Equivalents per Share	0.37	2.23	1.8	0.9	0.28	0.69	0.2	1.28	1.18	1.26	1.89	3.69	2.54	1.33	1.99
Book Value per Share	-46.56	-5.36	-3.67	-4.58	-6.03	-6.03	-4.43	-3.38	-2.92	-3	-3.56	-3.96	-4.1	-4.25	-4.26
Tangible Book Value per Share	-4.27	2.22	1.75	0.79	-0.73	0.1	-0.12	0.89	0.98	0.93	-0.24	0.04	-2.82	-3.3	-3.39

Harrow Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)